pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Marketed
Xembify
Xembify (immune globulin (human)-klhw)
Primary Immune Deficiency (PID)
Grifols Biologicals Inc (Inactive)
0
catalysts
Marketed
Xgeva
Xgeva (denosumab)
Bone Metastasis
$AMGN
AMGEN INC
0
catalysts
Phase 2
XmAb bispecific antibody
Unspecified Cancer
$NVS
NOVARTIS AG
0
catalysts
Marketed
← prev
page 177 of 271
next →
131
Pain
89
Neurology
1
Xphozah
Xphozah (tenapanor hydrochloride)
Hyperphosphatemia In Chronic Kidney Disease
$ARDX
ARDELYX, INC.
0
catalysts
Phase 2
YA-101
Multiple System Atrophy (Multi-System Degeneration)
Yoda Pharmaceuticals Inc
0
catalysts
YARTEMLEA
YARTEMLEA (NARSOPLIMAB-WUUG)
1 INDICATIONS AND USAGE YARTEMLEA is indicated for the treatment of adult and…
$OMER
OMEROS CORP
0
catalysts
Preclinical
YB-200
Hepatocellular Carcinoma
Ymmunobio AG
0
catalysts
Phase 1
YENEO-001
Colorectal Cancer
NantBio Inc
0
catalysts
YESINTEK
YESINTEK (USTEKINUMAB-KFCE)
1 INDICATIONS AND USAGE YESINTEK is a human interleukin-12 and -23 antagonist…
$HCWB
HCW Biologics Inc.
0
catalysts
Phase 2
YG-1699
Type 1 Diabetes (Juvenile Diabetes)
Youngene Therapeutics Co Ltd
0
catalysts
Phase 1
YH-013
Solid Tumor
Eucure (Beijing) Biopharma Co Ltd
0
catalysts
Phase 2
YH-12852
Diabetic Gastroparesis
$PCSA
Processa Pharmaceuticals, Inc.
0
catalysts
Phase 2
YH-42946
Non-Small Cell Lung Cancer
Yuhan Corp
0
catalysts
Phase 2
YL-13027
Solid Tumor
Shanghai Yingli Pharmaceutical Co Ltd
0
catalysts
Phase 2
YL-15293
Colorectal Cancer
Shanghai Yingli Pharmaceutical Co Ltd
0
catalysts
Phase 1
YL-217
Colorectal Cancer
Suzhou Medilink Therapeutics Ltd
0
catalysts
Preclinical
YN-014
Alzheimer's Disease
Shanghai Innogen Pharmaceutical Technology Co Ltd
0
catalysts
YORVIPATH
YORVIPATH (PALOPEGTERIPARATIDE)
1 INDICATIONS AND USAGE YORVIPATH is indicated for the treatment of hypoparat…
Parathyroid hormone/parathyroid hormone-related peptide receptor
$ASND
Ascendis Pharma A/S
0
catalysts
Phase 2
YPP-10
Keratoconjunctivitis Sicca (Dry Eye)
Yuyu Pharma Inc
0
catalysts
Phase 2
YR-001
Atopic Dermatitis (Atopic Eczema)
YIRUI Pharmaceutical Technology Co Ltd
0
catalysts
Phase 1
YUQA-1007
Inflammatory Bowel Disease
AllianThera Biopharma
0
catalysts
YUVIWEL
YUVIWEL (NAVEPEGRITIDE)
Ascendis Pharma Inc
0
catalysts
Marketed
Yasmin
Yaz ((drospirenone + ethinylestradiol))
Acne Vulgaris
Bayer HealthCare Pharmaceuticals Inc
0
catalysts
Phase 3
Yimmugo
Yimmugo (immune globulin (human))
Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura)
$GRFS
Grifols SA
0
catalysts
Marketed
Yonsa
Yonsa (abiraterone acetate)
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Sun Pharmaceutical Industries Ltd
0
catalysts
ZEJULA
ZEJULA (NIRAPARIB TOSYLATE)
GlaxoSmithKline LLC
0
catalysts
Phase 2
ZEN-3694
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Zenith Epigenetics Ltd
0
catalysts
ZENATANE
ZENATANE (ISOTRETINOIN)
INDICATIONS AND USAGE Severe Recalcitrant Nodular Acne Zenatane is indicated…
Retinoic acid receptor
$RDY
DR REDDYS LABORATORIES LTD
0
catalysts
Phase 2
ZEP-3
Herpes Labialis (Oral Herpes)
Shulov Innovative Science Ltd
0
catalysts
ZEPZELCA
ZEPZELCA (LURBINECTEDIN)
1 INDICATIONS AND USAGE ZEPZELCA is an alkylating drug indicated: • in combin…
$JAZZ
Jazz Pharmaceuticals plc
0
catalysts
